{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:50:42Z","timestamp":1792180242654,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.vaccine.2007.07.060","type":"journal-article","created":{"date-parts":[[2007,8,18]],"date-time":"2007-08-18T07:16:50Z","timestamp":1187421410000},"page":"7041-7046","source":"Crossref","is-referenced-by-count":49,"title":["Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains"],"prefix":"10.1016","volume":"25","author":[{"given":"Yoshio","family":"Tano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorihiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunsiti","family":"Simizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Miyamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.07.060_bib1","unstructured":"Laboratory surveillance for wild and vaccine-derived polioviruses, January 2003\u2013June 2004. Weekly Epidemiological Record 2004;79:393\u2013400."},{"key":"10.1016\/j.vaccine.2007.07.060_bib2","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1056\/NEJMp068200","article-title":"The eradication of polio\u2014progress and challenges","volume":"355","author":"Pallansch","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.07.060_bib3","first-page":"16","article-title":"Circulating vaccine-derived polioviruses: current state of knowledge","volume":"82","author":"Kew","year":"2004","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2007.07.060_bib4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/clinids\/14.2.568","article-title":"Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease","volume":"14","author":"Strebel","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.060_bib5","first-page":"40","article-title":"Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission","volume":"82","author":"Aylward","year":"2004","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2007.07.060_bib6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2007.07.060_bib7","unstructured":"Vaccine-derived polioviruses\u2014update. Wkly Epidemiol Rec 2006;81:398\u2013404."},{"key":"10.1016\/j.vaccine.2007.07.060_bib8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/434699a","article-title":"A global call for new polio vaccines","volume":"434","author":"Heymann","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2007.07.060_bib9","first-page":"163","article-title":"Progress with inactivated poliovirus vaccines derived from the Sabin strains","volume":"105","author":"Doi","year":"2001","journal-title":"Dev Biol"},{"key":"10.1016\/j.vaccine.2007.07.060_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.biologicals.2006.02.010","article-title":"Development of inactivated poliovirus vaccine derived from Sabin strains","volume":"34","author":"Simizu","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2007.07.060_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1099\/0022-1317-74-4-685","article-title":"Antigenic structure of poliovirus in inactivated vaccines","volume":"74","author":"Ferguson","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2007.07.060_bib12","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1099\/vir.0.19088-0","article-title":"Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains","volume":"84","author":"Martin","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2007.07.060_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biologicals.2004.11.001","article-title":"Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method","volume":"33","author":"Rezapkin","year":"2005","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2007.07.060_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/1045-1056(95)90017-9","article-title":"A WHO collaborative study on assays of the antigenic content of inactivated poliovirus vaccines","volume":"23","author":"Wood","year":"1995","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2007.07.060_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0264-410X(95)00159-X","article-title":"The use of antipoliovirus monoclonal antibodies as an improved safety test for oral live poliomyelitis vaccine","volume":"14","author":"Horie","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.060_bib16","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/424524","article-title":"Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy","volume":"190","author":"Dragunsky","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.060_bib17","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0264-410X(98)00409-5","article-title":"Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains","volume":"9","author":"Kersten","year":"1999","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07008985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07008985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T22:21:26Z","timestamp":1546640486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07008985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":17,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0264410X07008985"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.07.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}